ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,624Medicare Part D Prescriptions Filled, Including Refills

Rank: 34 out of 1269

$724K Total Retail Price of All Prescriptions

Rank: 53 out of 1269

421 Patients Receiving at Least One Drug in Part D
78%Patients 65 Years and Older
90% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Maryland
Lower avg

Schedule Two
Controlled Substances

12% of this provider’s 421 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

13% of this provider’s 421 patients filled at least one prescription for a schedule three drug, compared to an average of 5%.

Risky Drugs to Seniors

1% of this provider’s 12,035 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

29% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$53 was the average price of a prescription from this provider, compared to $69 among peers.

Prescriptions per Patient

32 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Maryland
LISINOPRIL 767 630 1 1
AMLODIPINE BESYLATE 666 594 2 2
FUROSEMIDE 536 494 3 5
SIMVASTATIN 513 428 4 3
DONEPEZIL HCL 308 308 5 22
ATORVASTATIN CALCIUM 304 282 6 7
METOPROLOL TARTRATE 271 251 7 6
METOPROLOL SUCCINATE 243 220 8 13
GABAPENTIN 225 215 9 17
HYDRALAZINE HCL 223 192 10 48
LEVOTHYROXINE SODIUM 203 195 11 4
HYDROCHLOROTHIAZIDE 199 146 12 10
LEVETIRACETAM 190 188 13 55
METFORMIN HCL 189 144 14 9
WARFARIN SODIUM 182 172 15 12
LOSARTAN POTASSIUM 177 159 16 15
LANTUS 176 151 17 39
POTASSIUM CHLORIDE 175 166 18 26
MIRTAZAPINE 168 166 19 24
CARVEDILOL 151 124 20 29
OMEPRAZOLE 150 130 21 8
KLOR-CON M20 150 128 21 60
ACETAMINOPHEN-CODEINE 149 136 S3 23 98
NIFEDIPINE ER 146 117 24 65
LACTULOSE 135 133 25 67
CLOPIDOGREL 118 95 26 32
RANITIDINE HCL 117 109 27 27
DIOVAN 108 107 28 35
ATENOLOL 108 103 28 14
CLONIDINE HCL 105 89 30 51
NOVOLOG 104 89 31 82
IBUPROFEN 103 84 32 73
CITALOPRAM HBR 100 78 33 21
ALENDRONATE SODIUM 95 95 34 28
PLAVIX 92 80 35 47
RISPERIDONE 88 86 36 43
PHENYTOIN SODIUM EXTENDED 88 84 36 137
SPIRIVA 83 78 38 64
LIDODERM 82 80 39 56
NAMENDA 78 78 40 38
SERTRALINE HCL 74 72 41 23
BRIMONIDINE TARTRATE 74 73 41 205
TRAMADOL HCL 74 59 41 16
PREDNISONE 73 65 44 45
PROAIR HFA 73 48 44 61
COLCRYS 72 69 46 150
SANTYL 71 69 47 101
NEXIUM 71 63 47 41
LATANOPROST 71 69 47 143
TAMSULOSIN HCL 69 65 50 31
FLUTICASONE PROPIONATE 68 40 51 40
LISINOPRIL-HYDROCHLOROTHIAZIDE 65 41 52 33
GLIPIZIDE 64 53 53 37
CRESTOR 63 63 54 25
AGGRENOX 63 51 54 253
GLIPIZIDE ER 62 45 56 102
HYDROCORTISONE 61 45 57 301
DIOVAN HCT 59 47 58 76
AMITIZA 58 52 59 299
LIPITOR 58 47 59 91
LOVASTATIN 57 57 61 30
PRAVASTATIN SODIUM 56 53 62 11
VENTOLIN HFA 55 44 63 100
DIGOXIN 54 47 64 62
ISOSORBIDE MONONITRATE ER 53 53 65 63
OXYCODONE-ACETAMINOPHEN 52 30 S2 66 44
SPIRONOLACTONE 52 48 66 77
HYDROCODONE-ACETAMINOPHEN 52 24 S3 66 20
DORZOLAMIDE-TIMOLOL 50 49 69 394
ADVAIR DISKUS 50 40 69 46
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 27, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.